Short communication
In vitro aggregation facilitates β-amyloid peptide-(25–35)-induced amnesia in the rat

https://doi.org/10.1016/S0014-2999(96)00922-3Get rights and content

Abstract

The β-amyloid peptide-(25–35) fragment, but not β-amyloid peptide-(1–28), shares with β-amyloid protein-(1–42) the ability to self-aggregate and to induce neurotoxicity in vitro. This study examined the induction of amnesia in rats given intracerebroventricularly soluble or aggregated β-amyloid peptide-(25–35) (5–45 nmol), or β-amyloid peptide-(1–28) (15 nmol). Memory deficit in the water-maze test, examined 14 days after aggregated β-amyloid peptide-(25–35) injection, was more pronounced than with soluble β-amyloid peptide-(25–35). β-Amyloid peptide-(1–28) only affected retention. These results confirm the direct amnesic properties of β-amyloid peptides in the rat brain and showed that prior peptide aggregation markedly facilitates the appearance of amnesia.

References (16)

There are more references available in the full text version of this article.

Cited by (127)

  • Topographical memory analyzed in mice using the Hamlet test, a novel complex maze

    2018, Neurobiology of Learning and Memory
    Citation Excerpt :

    The proof-of-concept experiment used the pharmacological model induced by ICV injection of oligomerized Aβ25–35 peptide (Maurice et al., 1996). This AD-like model is widely used in pharmacological screening since it presents a high descriptive validity, a good predictive validity towards more elaborated transgenic mouse models of AD, and a short onset in the appearance of behavioural deficits and toxicity, within 1–2 weeks after peptide injection in mice and rats (Maurice et al., 1996; Delobette, Privat, & Maurice, 1997; Meunier et al., 2006; Klementiev et al., 2007; Chavant et al., 2010). Numerous aspects of the toxicity are rapidly observed, including oxidative stress, neuroinflammation, apoptosis, synaptic and cellular losses, amyloid accumulation, Tau hyperphosphorylation and activation of the related kinases.

  • Effect of amyloid-Β (25–35) in hyperglycemic and hyperinsulinemic rats, effects on phosphorylation and O-GlcNAcylation of tau protein

    2017, Neuropeptides
    Citation Excerpt :

    Insulin levels were determined using rat insulin ELISA kit obtained from Crystal Chem Inc. (Chicago, IL, USA). The Aβ25–35 peptide (100 μM) was dissolved in sterile water (Pike et al., 1995), and incubated at 37 °C for 24 h to favor its aggregation, before injecting into animals (Maurice et al., 1996; Delobette et al., 1997). Peptide aggregation was confirmed by light-scatter tests using Malvern Z-sizer, Grovewood Road on the peptide, which indicate 10,000,000 Da for aggregated ßA peptide based on the size calculated by the equipment Fig. 2.

View all citing articles on Scopus
View full text